Analytical Lens: Exploring Fulcrum Therapeutics Inc (FULC)’s Financial Story Through Ratios

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

The closing price of Fulcrum Therapeutics Inc (NASDAQ: FULC) was $3.24 for the day, down -9.75% from the previous closing price of $3.59. In other words, the price has decreased by -$9.75 from its previous closing price. On the day, 0.7 million shares were traded.

Ratios:

Our analysis of FULC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 22.63 and its Current Ratio is at 22.63. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on September 13, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $17 previously.

RBC Capital Mkts Downgraded its Outperform to Sector Perform on September 12, 2024, whereas the target price for the stock was revised from $15 to $4.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 07 ’24 when Tourangeau Greg sold 236 shares for $7.76 per share. The transaction valued at 1,831 led to the insider holds 11,571 shares of the business.

Tourangeau Greg sold 4,884 shares of FULC for $57,219 on Mar 08 ’24. The Vice President, Finance now owns 11,807 shares after completing the transaction at $11.72 per share. On Mar 04 ’24, another insider, Sapir Alex, who serves as the insider of the company, bought 43,360 shares for $11.35 each. As a result, the insider paid 492,028 and bolstered with 43,360 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.19 while its Price-to-Book (P/B) ratio in mrq is 0.72.

Stock Price History:

Over the past 52 weeks, FULC has reached a high of $13.70, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is -20.71%, while the 200-Day Moving Average is calculated to be -41.50%.

Shares Statistics:

A total of 53.97M shares are outstanding, with a floating share count of 47.84M. Insiders hold about 11.37% of the company’s shares, while institutions hold 86.71% stake in the company.

Most Popular